How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association, Schizophr Bull, vol.37, pp.811-821, 2011. ,
Un diagnostic méconnu: la schizophrénie chez l'enfant, Ann Méd Psychol, vol.161, pp.652-659, 2003. ,
Anxiété et schizophrénie : situation actuelle, Ann Méd Psychol, vol.158, pp.741-749, 2000. ,
La schizophrénie, Encyclopédie orphanet. Inserm, 2004. ,
Predictors of psychosis: a 50-year follow-up of the Lundby population, Eur Arch Psychiatry Clin Neurosci, vol.260, pp.113-125, 2010. ,
Mechanisms of relapse prevention in schizophrenia, Pharmacopsychiatry, vol.37, pp.141-147, 2004. ,
Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples, Psychiatry Res, vol.144, pp.153-166, 2006. ,
Social anxiety in outpatients with schizophrenia: a relevant cause of disability, Am J Psychiatry, vol.161, pp.53-58, 2004. ,
The quality of life of the mentally ill living in residential facilities, Eur Arch Psychiatry Clin Neurosci, vol.256, pp.372-381, 2006. ,
Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study, Schizophr Res, vol.111, pp.153-158, 2009. ,
Can we harness computerised cognitive bias modification to treat anxiety in schizophrenia? A first step highlighting the role of mental imagery, Psychiatry Res, vol.178, pp.451-455, 2010. ,
Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping, J Ment Health, vol.19, pp.184-192, 2010. ,
Theory of mind and global empathy performance in schizophrenia: the role of anxiety, remission status and symptom type, Schizophr Res, vol.117, p.327, 2010. ,
Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia, Clin Schizophr Relat Psychoses, vol.4, pp.41-48, 2010. ,
Anxiety disorders in schizophrenia, Comp Psychiatry, vol.45, pp.460-468, 2004. ,
Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life, J Psychiatric Res, vol.39, pp.409-414, 2005. ,
Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor, J Nerv Ment Dis, vol.189, pp.669-675, 2001. ,
Quality of life in schizophrenia: contributions of anxiety and depression, Schizophr Res, vol.51, pp.171-180, 2001. ,
Deficits in theory of mind and social anxiety as independent paths to paranoid features in schizophrenia, Schizophr Res, vol.124, pp.81-85, 2010. ,
, Eur Arch Psychiatry Clin Neurosci, vol.264, pp.171-178, 2014.
Angoisse psychotique et angoisse névrotique, Différence qualitative ou différence quantitative? L'Encéphale 9, pp.211-216, 1983. ,
Panic-like'' symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications, Comp Psychiatry, vol.32, pp.465-473, 1991. ,
Prise en charge médicamenteuse de l'anxiété chez le patient souffrant de schizophrénie, L'Encéphale, vol.37, pp.83-89, 2011. ,
Psychotic anxiety scale (PAS): évaluation de la fidélité intercotateurs et analyse factorielle des correspondances, L'Encéphale, vol.15, pp.543-547, 1989. ,
Efficacité de l'acétate de zuclopenthixol sur l'anxiété psychotique évaluée lors d'une étude ouverte, L'Encéphale, vol.22, pp.280-286, 1996. ,
Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients, J Clin Psychopharmacol, vol.16, pp.38-44, 1996. ,
The assessment of anxiety states by rating, Br J Med Psychol, vol.32, pp.50-55, 1959. ,
The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale, J Neurol Neurosurg Psychiatry, vol.47, pp.970-975, 1984. ,
The AMDP-System. Manual for the assessment and documentation of psychopathology, 1982. ,
A comprehensive psychopathological rating scale, Acta Psychiatrica Scandinavica Suppl, vol.271, pp.5-27, 1978. ,
La version française de la CPRS: analyse factorielle sur un échantillon de 208 patients, L'Encéphale, vol.2, pp.395-400, 1987. ,
Une analyse factorielle de l'échelle d'appréciation de l'anxiété de Hamilton, pp.183-189, 1981. ,
L'échelle brève d'anxiété de Tyrer en pratique extrahospitalière: première validation en langue française, L' Encéphale, vol.15, pp.535-542, 1989. ,
Preliminary construction and validation of an anxiety scale derived from the French version of the AMDP, the AMDP-AT, Encephale, vol.11, pp.107-111, 1985. ,
A technique for the measurement of attitudes, Archives Psychol, vol.140, pp.5-55, 1932. ,
An exploration of the psychometric properties of the French-language version of the positive and negative syndrome scale (PANSS), Can J Psychiatry, vol.13, pp.893-900, 1999. ,
An index of factorial simplicity, Psychometrika, vol.39, pp.31-36, 1974. ,
The sources of four commonly reported cutoff criteria, what did they really say?, Organizational Res Meth, vol.9, pp.202-220, 2006. ,
Intraclass correlations: uses in assessing rater reliability, Psychol Bull, vol.86, pp.420-428, 1979. ,
An easy guide to factor analysis, 1994. ,
The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophrenia Bull, vol.13, pp.261-274, 1987. ,
Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms, CNS Spectr, vol.10, pp.721-731, 2005. ,
Effects of risperidone on affective symptoms in patients with schizophrenia, Int Clin Psychopharmacol, vol.15, pp.343-349, 2000. ,
Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol, Arch Gen Psychiatry, vol.55, pp.250-258, 1998. ,
The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials, J Clin Psychopharmacol, vol.28, pp.544-549, 2008. ,
Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride, Am J Psychiatry, vol.156, pp.610-616, 1999. ,
Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients, Schizophr Res, vol.78, pp.157-159, 2005. ,
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial, Prog Neuropsychopharmacol Biol Psychiatry, vol.31, pp.1504-1509, 2007. ,